Safety and efficacy of AST-001 in children with autism spectrum disorder: a 52-week multicenter long-term follow-up study

BackgroundThis study examined the 52-week safety and efficacy of AST-001 syrup for the core symptoms of autism spectrum disorder (ASD) in children aged 2–11 years.MethodsThis multicenter long-term follow-up study enrolled children with ASD who were identified as responders in an antecedent phase II...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Johanna Inhyang Kim, Hyo-Won Kim, Ji-Hoon Kim, MoonSoo Lee, Su-Kyeong Hwang, Yoo-Sook Joung
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-06-01
Serie:	Frontiers in Psychiatry
Soggetti:	AST-001 autism children clinical trial long term safety
Accesso online:	https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1783915/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!